Cardiovascular Disorders and Pregnancy Complications Post-COVID-19: Investigating the Potential Role of Vaccination

Abstract

In a detailed study of 420 pregnant women in the last trimester from southern and central Iraq, aged 15 to 36 years, the impact of COVID-19 vaccinations on cardiovascular risk factors was assessed. The study's cohort displayed diverse vaccination statuses, with 50% receiving two vaccine doses and 10% receiving one dose, involving brands like Pfizer and Sinopharm. The findings indicated a notable distinction in cardiovascular responses between vaccinated and unvaccinated pregnant women. Vaccination seemed to reduce certain cardiovascular risks during pregnancy in the COVID-19 era. However, the extent of risk mitigation varied based on the number of vaccine doses and the vaccine type. In summary, the research suggests a potential protective effect of full COVID-19 vaccination against cardiovascular risks in pregnancy. These results highlight the need for further investigations into the specific effects of different COVID-19 vaccines on cardiovascular health in pregnancy.